Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-139,682
Closed -$15.9M 293
2024
Q3
$15.9M Sell
139,682
-698
-0.5% -$82.9K 0.79% 34
2024
Q2
$17.4M Buy
140,380
+12,304
+10% +$1.58M 0.93% 28
2024
Q1
$16.9M Buy
128,076
+4,051
+3% +$499K 0.9% 32
2023
Q4
$13.5M Sell
124,025
-15,365
-11% -$1.59M 0.81% 33
2023
Q3
$14.4M Sell
139,390
-46,268
-25% -$4.99M 0.89% 31
2023
Q2
$21.4M Sell
185,658
-748
-0.4% -$84.9K 1.31% 13
2023
Q1
$19.8M Sell
186,406
-122,085
-40% -$13.2M 1.25% 17
2022
Q4
$34.2M Sell
308,491
-88,384
-22% -$9.03M 1.89% 5
2022
Q3
$34.2M Sell
396,875
-49,090
-11% -$4.38M 2.15% 3
2022
Q2
$40.7M Buy
445,965
+56,070
+14% +$4.97M 2.45% 3
2022
Q1
$32M Buy
+389,895
New +$30.7M 1.63% 4
2014
Q3
Sell
-202,453
Closed -$11.2M 266
2014
Q2
$11.2M Sell
202,453
-3,390
-2% -$185K 1.04% 20
2014
Q1
$11.2M Buy
+205,843
New +$10.7M 1.04% 18

Other funds holding MRK

Foundry Partners's MRK Position: Q4 2024 in Review

Foundry Partners sold out of Merck (MRK) in Q4 2024, closing a stake of 139,682 shares — an estimated $15.9M sold.

Foundry Partners first reported a position in MRK in Q1 2014 and held it in 13 quarters. The position peaked at $40.7M in Q2 2022. 3,607 funds tracked by Wall St. Rank hold MRK as of Q4 2024.

  • Foundry Partners reported no remaining Merck position as of Q4 2024 after selling out during the quarter.
  • Foundry Partners sold 139,682 Merck shares in Q4 2024, an estimated $15.9M.
  • Foundry Partners first reported a position in Merck in Q1 2014 and held it in 13 quarters.
  • Foundry Partners's Merck position peaked at $40.7M in Q2 2022.
  • 3,607 funds tracked by Wall St. Rank held Merck as of Q4 2024.

Based on Foundry Partners's 13F filing for Q4 2024, filed 12 Feb 2025.